UnitedHealth Group Incorporated
NYSE-UNH
Company Overview
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Name
UnitedHealth Group Incorporated
CEO
Sir Andrew Philip Witty
Website
www.unitedhealthgroup.com
Sector
Health Care Providers and Services
Year Founded
1974
Profile
Market Cap
—
EV
—
Shares Out
—
Revenue
$393.9B
Employees
440,000
Margins
Gross
22.87%
EBITDA
8.89%
Operating
8.18%
Pre-Tax
5.11%
Net
3.63%
FCF
3.32%
Returns (5Yr Avg)
ROA
7.88%
ROTA
27.25%
ROE
22.67%
ROCE
19.04%
ROIC
10.56%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
—
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$32.4B
Net Debt
$45.61B
Debt/Equity
0.75
EBIT/Interest
8.63
Growth (CAGR)
Rev 3Yr
12.14%
Rev 5Yr
10.45%
Rev 10Yr
11.88%
Dil EPS 3Yr
-1.53%
Dil EPS 5Yr
2.28%
Dil EPS 10Yr
10.71%
Rev Fwd 2Yr
—
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
—
EPS LT Growth Est
—
Dividends
Yield
—
Payout
51.26%
DPS
$7.96
DPS Growth 3Yr
13.81%
DPS Growth 5Yr
14.99%
DPS Growth 10Yr
19.77%
DPS Growth Fwd 2Yr
—